Levosimendan vs Dobutamine
COMPARISON EVIDENCE Mebazza, (2007) SURVIVE – Levosimendan vs Dobutamine in patients with acute decompensated heart failure, JAMA n = 1320-> no difference in 180 day mortality References and Links LITFL CCC — Dobutamine CCC — Levosimendan